Device / Technology News

RSS

Semi-automatic catheter insertion gun reduces pain in hospitalized children

Administering fluids to patients is carried out through intravenous (IV) catheters, inserting a needle in a vein in a common medical procedure. However, the motor coordination required to insert an IV catheter is very demanding, particularly in children and infants. This often causes pain, distress and frustration.

4 Sep 2013

Study shows surgical robot technology reports misleading picture of safety

Despite widespread adoption by hospitals of surgical robot technology over the past decade, a "slapdash" system of reporting complications paints a , according to Johns Hopkins researchers.

4 Sep 2013

Researchers develop novel transparent skull implant that provides a window to the brain

A team of University of California, Riverside researchers have developed a novel transparent skull implant that literally provides a "window to the brain", which they hope will eventually open new treatment options for patients with life-threatening neurological disorders, such as brain cancer and traumatic brain injury.

4 Sep 2013

BIDMC receives grant to study new noninvasive neurophysiologic intervention for spinal cord injuries

Beth Israel Deaconess Medical Center has been awarded a grant from the National Institutes of Health to investigate the use of a new noninvasive neurophysiologic intervention for the treatment of patients with spinal cord injuries.

4 Sep 2013

Implantation rate of CIEDs continues to rise in most European countries

Infections cause a lower proportion of lead extractions than expected, according to preliminary results from the ELECTRa Registry presented at ESC Congress 2013 today by Dr Maria Grazia Bongiorni from Italy.

3 Sep 2013

VolitionRx-led consortium receives grant to develop novel NuQ biomarkers for immune response

...

3 Sep 2013

BME introduces new, improved Speed Continuous Active Compression System

BME, Inc., the privately held U.S. Leader in Nitinol Technology Implants and Instruments known under the brands of: Speed™ (fully-disposable continuous active compression system), HammerLock® (intramedullary hammertoe correction system), OSStaple™ (Nitinol continuous active compression system) and OSSforce™ (heat-activating implant controller), has announced today its' introduction of a new, improved Speed™ Continuous Active Compression System.

3 Sep 2013

Sigma Life Science signs license agreement with Horizon Discovery for CompoZr ZFN technology

Sigma-Aldrich Corporation today announced that Sigma Life Science, its innovative biological products and services business, has entered a non-exclusive license agreement with Horizon Discovery for use of Sigma's CompoZr Zinc Finger Nuclease technology.

3 Sep 2013

Imaxio's pro-immunogenic technology used in tuberculosis vaccine phase I clinical study

Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.

3 Sep 2013

Cambridge Epigenetix’s pioneering TrueMethyl™ kit proves successful in beta trial

Cambridge Epigenetix Ltd. (CEGX), a leader in epigenetics tools innovation, today published the results of a successful beta trial evaluating their pioneering TrueMethyl™ oxidative bisulfite sequencing (oxBS-Seq) technology.

3 Sep 2013

Researchers examine how online social network activities influence smoking, alcohol use

Teenagers who see friends smoking and drinking alcohol in photographs posted on Facebook and Myspace are more likely to smoke and drink themselves, according to a new study from the University of Southern California (USC).

3 Sep 2013

New model to predict which patients are most likely to have severe kidney failure from rhabdomyolysis

Researchers from Brigham and Women's Hospital (BWH) have developed a risk score calculation that can help predict which patients with rhabdomyolysis (a condition that occurs due to muscle damage) may be at risk for the severe complication of kidney failure or death.

3 Sep 2013

Facebook groups are effective tool for increasing HIV testing among at-risk populations

Peer-led Facebook groups are an acceptable and effective tool for increasing home-based HIV testing among at-risk populations. HIV infection is a major health concern for men who have sex with men (MSM), especially among African Americans and Latinos who have high rates of incident cases and new diagnoses.

3 Sep 2013

New prototype device for safe IV insertion reduces pain in hospitalized children

A new prototype device for rapid and safe IV insertion reduces pain in hospitalized children. The semi-automatic handheld device, called SAGIV, identifies veins, inserts a needle and withdraws it in a single movement. It was developed by students and clinicians in the Biodesign program of the Hebrew University of Jerusalem and Hadassah Medical Center.

3 Sep 2013

New quick test promises to reduce economic, health burden of syphilis cases in Latin America

Demystifying the chemical processes that create a wine's aroma, and the invaluable potential application of that understanding in winemaking, is the new objective of scientists in Uruguay who, with European partners, also recently sequenced the genome of the high-value Tannat grape, from which "the most healthy of red wines" are fermented.

2 Sep 2013

ddPCR technology can be used to reproducibly quantify microRNA in plasma

A study published online in Nature Methods today demonstrated that Droplet Digital PCR (ddPCR-) technology can be used to precisely and reproducibly quantify microRNA (miRNA) in plasma and serum across different days, paving the way for further development of miRNA and other nucleic acids as circulating biomarkers.

2 Sep 2013

DE-MRI before ablation can stage atrial fibrosis and help predict success treatment

In patients with atrial fibrillation, delayed enhancement magnetic resonance imaging (DE-MRI) performed before ablative treatment can stage the degree of damaged heart tissue (atrial fibrosis) and help predict whether treatment will be successful or not, according to results of Delayed Enhancement - MRI determinant of successful Catheter Ablation of Atrial Fibrillation (DECAAF) trial.

2 Sep 2013

Researchers develop new model to predict treatment success more accurately

The HI virus is feared, not least, because of its great adaptability. If the virus mutates at precisely the point targeted by a drug, it is able to neutralise the attack and the treatment fails. To minimise these viral defence mechanisms, doctors treat patients with modern combination therapies involving the simultaneous administration of several drugs. This approach forces the virus to run through a series of mutations before it becomes immune to the drugs.

2 Sep 2013

Pacemakers implanted for slow heart rhythm restore life expectancy to normal levels

Pacemakers implanted for slow heart rhythm restore life expectancy to normal levels, reveals research presented at ESC Congress 2013 today by Dr Erik O. Udo from the Netherlands. The findings provide a new reference point for the prognosis of modern pacemaker patients.

2 Sep 2013

Reimbursement systems appear to impact on achievement of cholesterol lowering targets

Dr Gitt said: "There are wide variations between European countries in the achievement of LDL-cholesterol (LDL-C) targets. However the effect of different reimbursement systems on meeting the targets was unknown."

2 Sep 2013

Device / Technology News

Semi-automatic catheter insertion gun reduces pain in hospitalized children

Study shows surgical robot technology reports misleading picture of safety

Researchers develop novel transparent skull implant that provides a window to the brain

BIDMC receives grant to study new noninvasive neurophysiologic intervention for spinal cord injuries

Implantation rate of CIEDs continues to rise in most European countries

VolitionRx-led consortium receives grant to develop novel NuQ biomarkers for immune response

BME introduces new, improved Speed Continuous Active Compression System

Sigma Life Science signs license agreement with Horizon Discovery for CompoZr ZFN technology

Imaxio's pro-immunogenic technology used in tuberculosis vaccine phase I clinical study

Cambridge Epigenetix’s pioneering TrueMethyl™ kit proves successful in beta trial

Researchers examine how online social network activities influence smoking, alcohol use

New model to predict which patients are most likely to have severe kidney failure from rhabdomyolysis

Facebook groups are effective tool for increasing HIV testing among at-risk populations

New prototype device for safe IV insertion reduces pain in hospitalized children

New quick test promises to reduce economic, health burden of syphilis cases in Latin America

ddPCR technology can be used to reproducibly quantify microRNA in plasma

DE-MRI before ablation can stage atrial fibrosis and help predict success treatment

Researchers develop new model to predict treatment success more accurately

Pacemakers implanted for slow heart rhythm restore life expectancy to normal levels

Reimbursement systems appear to impact on achievement of cholesterol lowering targets

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News